| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 0.00 | £ 0.00 | £ 0.00 | £ 0.00 | £ 0.00 |
| Gross Profit | £ -59.00K | £ -114.00K | £ -26.00K | £ -26.00K | £ -18.00K |
| Operating Income | £ -6.42M | £ -6.62M | £ -5.04M | £ -4.99M | £ -2.38M |
| EBITDA | £ -6.36M | £ -6.00M | £ -4.66M | £ -4.75M | £ -2.32M |
| Net Income | £ -5.70M | £ -5.79M | £ -3.93M | £ -4.69M | £ -2.34M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 7.71M | £ 7.82M | £ 12.17M | £ 16.19M | £ 20.95M |
| Total Assets | £ 9.94M | £ 10.25M | £ 15.43M | £ 19.29M | £ 23.02M |
| Total Debt | £ 0.00 | £ 0.00 | £ 0.00 | £ 0.00 | £ 0.00 |
| Net Debt | £ -7.71M | £ -7.82M | £ -12.17M | £ -16.19M | £ -20.95M |
| Total Liabilities | £ 1.34M | £ 974.00K | £ 986.00K | £ 966.00K | £ 438.00K |
| Stockholders' Equity | £ 8.60M | £ 9.27M | £ 14.44M | £ 18.32M | £ 22.58M |
| Cash Flow | |||||
| Free Cash Flow | £ -4.84M | £ -4.78M | £ -4.02M | £ -4.96M | £ -2.23M |
| Operating Cash Flow | £ -4.51M | £ -4.65M | £ -3.85M | £ -4.37M | £ -2.15M |
| Investing Cash Flow | £ -80.00K | £ 299.00K | £ 359.00K | £ -388.00K | £ -81.00K |
| Financing Cash Flow | £ 4.48M | £ 0.00 | £ 0.00 | £ 0.00 | £ 23.18M |
Poolbeg Pharma Ltd. (DE:7JN)
FRANKFURT:7JN
